JGHCPCS Level II
Drug or biological acquired with 340b drug pricing program discount, reported
- Usage notes
- Append to a drug or biological HCPCS code to report that it was acquired under the 340B Drug Pricing Program, for entities required to report acquisition status.
- Common mistakes
- Applying JG under a payer's reporting rules that actually call for modifier TB instead — the two 340B-related modifiers serve different reporting contexts and aren't interchangeable.
Related modifiers
J1Competitive acquisition program no-pay submission for a prescription numberJ2Competitive acquisition program, restocking of emergency drugs after emergencyJ3Competitive acquisition program (cap), drug not available through cap asJ4Dmepos item subject to dmepos competitive bidding program that is furnished byJ5Off-the-shelf orthotic subject to dmepos competitive bidding program that isJAAdministered intravenouslyJBAdministered subcutaneouslyJCSkin substitute used as a graft
Frequently asked questions
What does modifier JG mean?
Drug or biological acquired with 340b drug pricing program discount, reported
When do I use modifier JG?
Append to a drug or biological HCPCS code to report that it was acquired under the 340B Drug Pricing Program, for entities required to report acquisition status.
What's a common mistake with modifier JG?
Applying JG under a payer's reporting rules that actually call for modifier TB instead — the two 340B-related modifiers serve different reporting contexts and aren't interchangeable.
HCPCS modifier data from CMS. CPT® is a registered trademark of the American Medical Association — CPT modifier descriptions are not included on this site. Always verify codes with authoritative sources before making billing decisions.